SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (7856)6/10/1999 11:27:00 AM
From: Brian Malloy  Read Replies (2) | Respond to of 9523
 
At $90 I would almost definitely be a buyer. Will it get there, hard to say. Those that want to own PFE for the longterm may want to nibble here at $100. Even if things improve, the stock may be stuck in a trading range from July to October or so.

Just watching for now. Praeto might say that bad news comes in threes'. 1) Viagra not selling as much as expected 2) Trovan will not sell as much as expected, then downgrades 3) ? {maybe, maybe not}.

Also, it doesn't help that the whole sector is under pressure. You have to ask yourself when will the sector begin to recover. The charts don't look positive at this point.